LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

Search

Intellia Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

12.15 -1.7

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.05

Max

12.39

Pagrindiniai rodikliai

By Trading Economics

Pajamos

106M

-96M

Pardavimai

-8M

15M

Pelnas, tenkantis vienai akcijai

-0.81

Pelno marža

-639.494

Darbuotojai

377

EBITDA

-2.9M

-98M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+73.91% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

235M

1.9B

Ankstesnė atidarymo kaina

13.85

Ankstesnė uždarymo kaina

12.15

Naujienos nuotaikos

By Acuity

19%

81%

28 / 342 reitingas Healthcare

Intellia Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-06-12 23:06; UTC

Social Media
News
ETF Constituents

Invesco QQQ Trust Series I gains after-market, supported by a strong Nasdaq close and SpaceX's debut, maintaining stability since Friday's close.

2026-06-12 20:07; UTC

News
Correlated Moves

The USD/DKK is trading higher, reflecting a modest increase since Thursday's close. The US Dollar Index also shows a slight uptick.

2026-06-12 20:07; UTC

News

The USD/CZK is trading lower today, reflecting a slight decline since Thursday's close. Recent U.S. producer price data has not significantly impacted the currency pair.

2026-06-12 20:07; UTC

News

Baker Hughes oil rig count rises to 433, influencing energy market sentiment. USD/PLN is trading roughly flat during Friday's session.

2026-06-12 20:07; UTC

Correlated Moves
Macro Event
News

The U.S. Baker Hughes oil rig count increased to 433, while the Michigan Consumer Sentiment Index rose to a preliminary reading of 48.9. USD/SGD is trading roughly flat.

2026-06-12 20:07; UTC

News

The U.S. Baker Hughes oil rig count rose to 433, while USD/THB trades roughly flat since Thursday's close amid routine market fluctuations.

2026-06-12 20:07; UTC

News
Macro Event

The USD/SEK exchange rate is lower today, despite a rise in U.S. consumer sentiment reported at 48.9, above expectations.

2026-06-12 20:07; UTC

News
Macro Event

USD/HUF trades lower despite a stronger-than-expected Michigan Consumer Sentiment Index, reflecting ongoing inflation concerns and unusual volatility during the session.

2026-06-12 20:07; UTC

News

The USD/ZAR is higher, supported by an increase in the Baker Hughes oil rig count, reflecting dynamics in the energy sector impacting currency valuations.

2026-06-12 20:02; UTC

News

ASML Holding NV is lower today, even as analysts note strengthening competitive advantages amid diminishing concerns over rival xLight and ongoing demand for its technology.

2026-06-12 20:02; UTC

News

Amazon.com Inc. shares are declining amid broadline retail sector weakness, despite recognition of Amazon Web Services as a growth driver.

2026-06-12 20:02; UTC

Macro Event
ETF Constituents
News
Macro News
Correlated Moves
Social Media

Financial Select Sector SPDR Fund is higher today, supported by gains in the financial sector and optimism over geopolitical stability following President Trump's Iran negotiations.

2026-06-12 20:02; UTC

News
Social Media

Intel's stock rises as Bank of America upgrades to Buy and Google orders three million processing units, reflecting strong market sentiment and bullish options flow.

2026-06-12 20:02; UTC

News

Cintas Corp shares are lower as the FTC issues a second request regarding its acquisition of UniFirst, signaling potential delays in the transaction.

2026-06-12 20:02; UTC

News

Adobe Inc. shares are trading lower amid analyst downgrades and CFO Dan Durn's upcoming departure. Concerns over a freemium model pressure near-term revenue outlook.

2026-06-12 20:01; UTC

News

Speculation about a merger involving Deutsche Telekom has boosted T-Mobile US shares. The stock has shown steady gains since Thursday's close, trading above its 20-day moving average.

2026-06-12 19:56; UTC

News
Correlated Moves
Macro Event

Broadcom Inc shares declined as broader market dynamics and economic data weighed on sentiment, despite record Q2 revenue and AI growth.

2026-06-12 19:52; UTC

News
Social Media

Workday Inc shares are lower today amid broader declines in the Application Software sector and an insider selling 107,500 shares at $135.54 to $140.37.

2026-06-12 19:52; UTC

News
Correlated Moves
Social Media

Wells Fargo raised Qualcomm's price target to $230, contributing to positive sentiment. The stock is trading higher amid optimism for upcoming Investor Day.

2026-06-12 19:52; UTC

News

Intuit Inc. shares are lower amid an investigation for securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues for DIY tax filers.

2026-06-12 19:51; UTC

News

Amgen Inc. is reassessing data on Tavneos amid FDA scrutiny. Shares are higher as the company challenges the proposal to withdraw the drug's approval.

2026-06-12 19:51; UTC

News
ETF Constituents

Health Care Select Sector SPDR Fund declines as key holdings falter, underperforming against gains in Energy, Materials, and Financials sectors.

2026-06-12 19:46; UTC

News
Social Media

Alphabet appeals a German court ruling on AI claims and announced a $50 million investment in workforce training, while shares are higher today.

2026-06-12 19:42; UTC

News
Social Media

Meta Platforms shares are lower amid reports of widespread service outages affecting Instagram, Facebook, and WhatsApp, with over 62,000 complaints noted.

2026-06-12 19:41; UTC

News

Analysts have raised earnings estimates for NetEase, reflecting positive sentiment. Shares are trading higher today, maintaining upward momentum since Thursday's close.

2026-06-12 19:41; UTC

News
Correlated Moves
Social Media

Advanced Micro Devices shares rose after Citi upgraded its rating to Buy and raised the price target to $575, citing strong GPU market potential.

2026-06-12 19:41; UTC

News
Correlated Moves

Applied Materials Inc is rising amid a broader market rally and Cantor Fitzgerald's price target increase to $650 from $575, reflecting strong investor interest.

2026-06-12 19:41; UTC

Social Media
News

WDC shares gain as JPMorgan raises price target to $650.

2026-06-12 19:41; UTC

Social Media
News
Correlated Moves
Macro Event

Lam Research Corp shares rise amid a market rally following President Trump's strike cancellation on Iran. Cantor Fitzgerald raised its price target to $425.

2026-06-12 19:41; UTC

News

Comcast Corp shares are higher today, driven by gains in the Cable & Satellite sector. The stock remains above Thursday's close despite a slight pullback.

Akcijų palyginimas

Kainos pokytis

Intellia Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

73.91% į viršų

12 mėnesių prognozė

Vidutinis 21.06 USD  73.91%

Aukščiausias 49 USD

Žemiausias 8 USD

Remiantis 18 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Intellia Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

18 ratings

8

Pirkti

8

Laikyti

2

Parduoti

Rinkos nuotaikos

By Acuity

28 / 342 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Intellia Therapeutics Inc

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat